Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106748605A details a green TBAB-Oxone method for o-dicarbonyl compounds, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102249937A details a low-cost, non-toxic synthesis for Ivabradine intermediates, offering significant supply chain advantages for API manufacturers.
Patent CN109678901B reveals a solvent-free halosilane-catalyzed route for trisubstituted phosphine oxides using alcohols, offering significant cost reduction and supply chain stability for pharmaceutical intermediates.
Patent CN115385920A details a scalable BTK inhibitor refining method achieving 99.4% purity without column chromatography, offering significant cost reduction in API manufacturing.
Novel 3-step route for kinase inhibitor intermediates eliminates high-pressure CO. Enhances safety and scalability for reliable pharmaceutical supply chains.
Patent CN113512733B details an electrochemical NHK reaction for Eribulin intermediate ERB, offering greener synthesis, reduced reaction time, and improved scalability for pharmaceutical manufacturing.
Patent CN104130092B details a novel one-step reductive coupling method. This breakthrough offers significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Discover the metal-free synthesis of dihydrophenanthroline compounds via patent CN112480112B. Achieve high purity and cost efficiency for pharmaceutical intermediates.
Novel patent CN103467287B offers efficient synthesis for Vitamin A intermediates. Achieve cost reduction and supply chain reliability with high-purity pharmaceutical intermediates.
Patent CN114195687A discloses a novel Pd-catalyzed synthesis of beta-chloro tetra-substituted alkenyl sulfones, offering high selectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN106146316A reveals high-selectivity boron catalysis for 1,2-diaryl ethylenediamines. Enables cost reduction and supply chain reliability in pharmaceutical intermediates manufacturing.
Patent CN113105301A details a novel ortho-carborane copper complex for mild Glaser coupling, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN114478290A reveals a metal halide catalyzed route for oseltamivir intermediates, offering superior purity and yield without column chromatography for reliable supply chains.
Patent CN102947000A details Z-M-OR complexes for efficient C-H and N-H carboxylation. Enables sustainable API intermediate synthesis using renewable CO2 feedstock.
Patent CN112608269B introduces a mild chalcogen weak interaction method for pyrrolidine synthesis, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Discover advanced processes for preparing cyclopenta[d]pyrimidin-4-yl piperazine compounds. Enhance supply chain reliability and reduce manufacturing costs for AKT inhibitors.
Patent CN111285769B details a polyionic liquid copper catalyst for efficient, green aqueous Henry reactions, offering high enantioselectivity and simplified supply chains for pharmaceutical intermediates.
Novel synthesis method for L-6-hydroxytryptophan derivatives offers high yield and scalable production for pharmaceutical intermediates and polypeptide drug development.
Novel imidazolium-functionalized ferrocene ligands enable high-yield asymmetric allylic substitution with recyclable catalyst properties for pharmaceutical intermediates.
Patent CN106946817A enables transition-metal-free synthesis of 1,2-dihydronaphthalene derivatives. This method offers high atom economy and simplified supply chain for pharmaceutical intermediates.